Eduardo Schenberg: Bringing MDMA Assisted Psychotherapy to Brazil

Brazil faces intense systemic challenges, characterized by widespread violence and a strained mental health infrastructure. Clinical trials investigating MDMA-assisted psychotherapy in Brazil offer a potential pathway for treating post-traumatic stress disorder and other severe psychiatric conditions. By confronting psychological shadows directly, patients can navigate past trauma in a supportive, non-directive clinical environment. Successful pilot studies have demonstrated robust outcomes, with a majority of severe PTSD patients meeting recovery criteria following therapy, and some benefits lasting for years. Scalability remains the primary concern, requiring substantial long-term funding and the training of a larger network of clinicians to implement these psychedelic-assisted treatments on a national scale.